|
Canada is an international centre for research and development with one of the largest biotechnology industries in the world. As the largest trading partner to the United States, Canada offers ready access to the North American market. Ottawa—Canada's capital—boasts the nation's third largest Life Sciences cluster and is part of Ontario's expanding bio-corridor.
Home to more than 140 Life Science companies, over 40 Life Sciences institutions, world-class research facilities, hospitals and universities; Ottawa is experiencing a biotech boom. Companies calling Ottawa home include MDS Nordion, Pfizer Manufacturing, Abbott Point of Care, Iogen, Aegera Oncology, Coley Pharmaceutical, Zelos Therapeutics, and Gamma-Dynacare Medical Laboratories
Ottawa is proud to possess world class, cutting-edge research in areas such as cardiovascular, biopharmaceuticals, cancer, neuroscience, vaccines, proteomics, stem cells, medical devices and bioproducts—among many others. Leading Canadian research institutions in Ottawa include the National Research Council of Canada, Health Canada, Agriculture and Agri-Food Canada, the University of Ottawa, Carleton University, Children's Hospital of Eastern Ontario (CHEO) and the Ottawa Health Research Institute (OHRI). Recently, $70 million was invested in the Stem Cell Research Centre to create a stem cell genomics and therapies centre of excellence.
Research will continue to be the driver of the biotech industry and Ottawa is well positioned to take advantage of its research and infrastructure strengths.
Since 1995 Ottawa has attracted over 50% of all incoming venture capital to Canada. Recent increases in capital investment, new company creation and community-based sector-building initiatives have resulted in a strong and sustainable life sciences sector. Since September 2001, millions in new investment have poured into Ottawa life science companies. Having been "discovered", Ottawa plans to build on its established track record—expanding investment networks and increasing the flow of capital for its increasing number of new startups.
With leading research institutions, established companies and emerging players, Ottawa is a prime career destination for anyone interested in the Life Sciences.
In addition, Ottawa is a major telecommunications and high-tech centre. It is a community with visionary entrepreneurs and has Canada’s highest level of research and development spending per capita. For more information on investment news, opportunities and resources visit us at www.olsc.ca.
Ottawa has:
- the 3rd largest life sciences community in Canada
- more than 140 life sciences companies
- over 40 life sciences research institutes and centres
- $350 million invested annually in local R&D projects
- 8-10 new spin-offs per year
- Canada’s federal government funding and regulatory agencies
The Ottawa Life Sciences Council (OLSC) and community are working to advance the Ottawa life sciences sector through various sector initiatives. The biotechnology industry in Ottawa is hot.
Adding to the biotechnology sector’s strength is the great quality of life found in Ottawa. Growing and vibrant, Ottawa is a clean, healthy community offering exceptional cultural, entertainment, leisure and sporting opportunities—just what you'd expect from the Canada's capital.
|
